Eric Xiao

Director/Board Member at

Emboline, Inc.

Health Technology

Finance

Consumer Services

Profile

Eric Xiao is currently a Director at Emboline, Inc. He previously worked as a Principal at Matrix Capital Management Co. LP from 2018 to 2022 and as a Board Member at Palleon Pharmaceuticals, Inc. from 2020 to 2022.
Mr. Xiao completed his undergraduate degree at Yale University in 2016.

Eric Xiao active positions

Companies	Position	Start
Emboline, Inc. Emboline, Inc. Medical SpecialtiesHealth Technology Develops novel embolic protection devices for transcatheter and surgical cardiac procedures	Director/Board Member	25/05/2021

All active positions of Eric Xiao

Former positions of Eric Xiao

Companies	Position	End
Matrix Capital Management Co. LP Matrix Capital Management Co. LP Investment ManagersFinance Matrix aims to generate an attractive risk-adjusted return by investing in a concentrated portfolio of long and short positions, following the classic hedge fund model. Their strategy is to achieve this goal through maintaining a concentrated portfolio of long and short investments, over the long-term, driven by differentiating research into company fundamentals. The firm performs a fundamental bottom-up analysis to assess a company’s intrinsic value.	Corporate Officer/Principal	01/02/2022
Palleon Pharmaceuticals, Inc. Palleon Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops glyco-immunology-based therapies to treat cancer and inflammatory diseases	Corporate Officer/Principal	01/02/2022

See the detail of Eric Xiao's experience

Training of Eric Xiao

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Eric Xiao's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Matrix Capital Management Co. LP Matrix Capital Management Co. LP Investment ManagersFinance Matrix aims to generate an attractive risk-adjusted return by investing in a concentrated portfolio of long and short positions, following the classic hedge fund model. Their strategy is to achieve this goal through maintaining a concentrated portfolio of long and short investments, over the long-term, driven by differentiating research into company fundamentals. The firm performs a fundamental bottom-up analysis to assess a company’s intrinsic value.	Finance
Yale University Yale University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Emboline, Inc. Emboline, Inc. Medical SpecialtiesHealth Technology Develops novel embolic protection devices for transcatheter and surgical cardiac procedures	Health Technology
Palleon Pharmaceuticals, Inc. Palleon Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops glyco-immunology-based therapies to treat cancer and inflammatory diseases	Health Technology

See company connections